NPPA fixes retail prices of 53 formulations, Details
New Delhi: Through recent notifications, the National Pharmaceutical Pricing Authority (NPPA), under the Ministry of Chemicals and Fertilizers, has fixed the retail price 53 formulations under Drugs (Price Control) Order, 2013.
The authority has fixed the retail prices based on decision on 130rd Authority meeting dated 25th August 2025.
The list includes Pure and Cure Healthcare/ Aurobindo Pharma' Acetylcysteine and Acebrophylline Tablets, Swiss Garnier Life Sciences/Workcell Solutions's Bisoprolol Fumarate and Amlodipine Besilate Tablets, Theon Pharmaceuticals/J.B Chemicals and Pharmaceuticals's Cefixime and Ofloxacin Oral Suspension, and others.
The list further includes Marine Medicare/ Alkem Laboratories's Calcium Citrate Malate and Vitamin D3 Tablets, Mascot Health Series Pvt & Macleods' Methylcobalamin, Alpha Lipoic Acid, Folic Acid, Pyridoxine HCl and Vitamin D3 tablets.
In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), has fixed, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer and marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1 | Acetylcysteine & Acebrophylline Tablets | Each film coated tablet contains: Acetylcysteine BP 600 mg Acebrophylline 100 mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. /M/s Aurobindo Pharma Ltd. | 14.98 |
2 | Bisoprolol Fumarate & Amlodipine Besilate Tablets | Each film coated tablet contains: Bisoprolol Fumarate IP 5 mg Amlodipine Besilate eq. to Amlodipine IP 5 mg | 1 Tablet | M/s Swiss Garnier Life Sciences/ M/s Workcell Solutions Pvt. Ltd. | 8.54 |
3 | Cefixime & Ofloxacin Oral Suspension | Each 5 ml of the reconstituted suspension contains: Cefixime Trihydrate IP eq. to Cefixime anhydrous 50 mg Ofloxacin IP 50 mg | 1 ML | M/s Theon Pharmaceuticals Ltd. /M/s J.B Chemicals & Pharmaceuticals Ltd. | 2.00 |
4 | Cefixime Oral Suspension IP (Combipack with Sterile Water) | Each Combipack contains:
Cefixime IP as Trihydrate eq. to Anhydrous Cefixime 200 mg
Each Vial Contains: Sterile Water for injections IP 30 ml | 1 ML | M/s Malik Lifesciences Pvt. Ltd./ M/s FDC Ltd. | 3.72 |
5 | Calcium Citrate Malate & Vitamin D3 Tablets | Each film coated tablet contains: Calcium Citrate Malate IP eq. to Elemental Calcium 250 mg Vitamin D3 IP 1000 IU | 1 Tablet | M/s Marine Medicare Pvt. Ltd. /M/s Alkem Laboratories Ltd. | 12.31 |
6 | Methylcobalamin, Alpha Lipoic Acid, Folic Acid, | Each film coated tablet contains: Methylcobalamin IP 1500 mcg | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s Macleods | 15.63 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Pyridoxine HCl & Vitamin D3 tablets | Alpha Lipoic Acid IP 100 mg Folic Acid IP 1.5 mg Pyridoxine HCl IP 3 mg Vitamin D3 IP 1000 IU | Pharmaceuticals Ltd. | |||
7 | Paracetamol, Phenylephrine HCl & Chlorpheniramine Maleate tablets | Each uncoated tablet contains: Paracetamol IP 500 mg Phenylephrine HCl IP 10 mg Chlorpheniramine Maleate IP 2 mg | 1 Tablet | M/s East African (India) Overseas/ M/s Micro Labs Ltd. | 4.81 |
8 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension | Each 5 ml contains: Paracetamol IP 250 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 2 mg | 1 ML | M/s Mascot Health Series Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 1.29 |
9 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension | Each 5 ml contains: Paracetamol IP 125 mg Phenylephrine Hydrochloride IP 5 mg Chlorpheniramine Maleate IP 1 mg | 1 ML | M/s Mascot Health Series Pvt. Ltd. / M/s Mankind Prime Labs Pvt. Ltd. | 1.17 |
10 | Dextromethorphan Hydrobromide, Chlorpheniramine Maleate & Phenylephrine Hydrochloride tablets | Each film coated tablet contains: Dextromethorphan Hydrobromide IP 10 mg Chlorpheniramine Maleate IP 2 mg Phenylephrine Hydrochloride IP 5 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 4.78 |
11 | Paracetamol & Caffeine Tablets | Each uncoated tablet contains: Paracetamol IP 650mg Caffeine IP (Anhydrous) 50 mg | 1 Tablet | M/s Juggat Pharma (Pharma Division of Jagdale Industries Pvt. Ltd.) | 3.61 |
12 | Ibuprofen & Paracetamol Suspension | Each 5 ml contains: Ibuprofen IP 100 mg Paracetamol IP 162.5 mg | 1 ML | M/s Shiva Biogenetic Pharmaceuticals Pvt. Ltd./ M/s Lupin Life Sciences Ltd. | 0.52 |
13 | Diclofenac sodium & Thiocolchicoside capsules | Each Hard Gelatin capsule contains: Diclofenac sodium IP 50 mg (as Diclofenac sodium Gastro- Resistant tablets IP) Thiocolchicoside IP 4 mg (as uncoated Thiocolchicoside tablet) | 1 Capsule | M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Dr. Reddy's Laboratories Ltd. | 16.90 |
14 | Domperidone & Naproxen Sodium | Each film coated tablet contains: Domperidone Maleate IP eq. to | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd./ | 8.49 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Tablets | Domperidone 10 mg, Naproxen Sodium USP 550 mg eq. to Naproxen 500 mg | M/s German Remedies Pharmaceuticals Pvt. Ltd. | |||
15 | Escitalopram Oxalate & Clonazepam tablets | Each film coated tablet contains: Escitalopram Oxalate IP Eq. to Escitalopram 20mg Clonazepam IP 0.5mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Limited / M/s Lupin Limited | 19.65 |
16 | Escitalopram Oxalate & Clonazepam tablets | Each film coated tablet contains: Escitalopram Oxalate IP Eq. to Escitalopram 5 mg Clonazepam IP 0.25mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Limited / M/s Lupin Limited | 7.96 |
17 | Lactulose Enema | Each ml contains: Lactulose Solution IP eq. to Lactulose 200 mg Sodium Benzoate IP 3mg (as preservative) | 1 ML | M/s Naxpar Pharma Pvt. Ltd./ M/s Abbott India Ltd. | 1.32 |
18 | Mefenamic Acid & Tranexamic Acid Tablets | Each Film Coated Tablet contains: Mefenamic Acid IP 250 mg Tranexamic Acid IP 500 mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Dr. Reddy's Laboratories Ltd. | 33.25 |
19 | Nebivolol Hydrochloride & Telmisartan tablets | Each uncoated bilayered tablet contains: Nebivolol Hydrochloride IP eq. to Nebivolol 5 mg Telmisartan IP 40 mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. /M/s German Remedies Pharmaceuticals Pvt. Ltd. | 15.60 |
20 | Telmisartan, Chlorthalidone & Metoprolol Succinate (ER) tablets | Each film coated bilayer tablet contains: Telmisartan IP 40 mg Chlorthalidone IP 12.5 mg Metoprolol Succinate IP 47.50 mg eq. to Metoprolol tartrate 50 mg (as Extended-release form) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 13.68 |
21 | Telmisartan, Cilnidipine & Metoprolol Succinate (ER) tablets | Each film coated bilayer tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Metoprolol Succinate IP 47.50 mg eq. to Metoprolol tartrate 50 mg (as Extended- release form) | 1 Tablet | M/s Mascot Health Series Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd. | 13.80 |
22 | Telmisartan, Cilnidipine & | Each film coated tablet contains: Telmisartan IP 40 mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd./ | 15.07 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Chlorthalidone tablets | Cilnidipine IP 10 mg Chlorthalidone IP 12.50 mg | M/s Cadila Pharmaceuticals Ltd. | |||
23 | Telmisartan, Cilnidipine & Metoprolol Succinate (ER) tablets | Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Metoprolol Succinate IP 23.75 mg eq. to Metoprolol tartrate 25 mg (as Extended-release form) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd. | 10.96 |
24 | Telmisartan, Cilnidipine & Metoprolol succinate (ER) tablets | Each film coated tablet contains: Telmisartan IP 40 mg Cilnidipine IP 10 mg Metoprolol Succinate IP 47.50 mg eq. to Metoprolol tartrate 50 mg (as Extended-release form) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd. | 13.68 |
25 | Vildagliptin (SR), Dapagliflozin & Metformin Hydrochloride (SR) tablets | Each film coated bilayered tablet contains: Vildagliptin IP 100 mg (as sustained release) Dapagliflozin propanediol USP eq. to Dapagliflozin 10mg Metformin Hydrochloride IP 500 mg (as sustained release) | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Blue Cross Laboratories Pvt. Ltd. | 12.50 |
26 | Dapagliflozin, Teneligliptin & Metformin Tablets | Each film coated bilayer tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg, Teneligliptin Hydrobromide Hydrate IP eq to Teneligliptin 20 mg Metformin Hydrochloride IP 500 mg (as sustained release) | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Blue Cross Laboratories Pvt. Ltd. | 11.60 |
27 | Linagliptin, Dapagliflozin & Metformin Hydrochloride (sustained release) tablets | Each film coated bilayer tablet contains: Linagliptin 5 mgDapagliflozin propanediol USP eq. to Dapagliflozin 10mg Metformin hydrochloride IP 500mg (As Sustained release form) | 1 Tablet | M/s Theon Pharmaceuticals Ltd./ M/s Akumentis Healthcare Ltd. | 18.50 |
28 | Sitagliptin & Metformin Hydrochloride (Sustained Release) | Each Film Coated Bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100 mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Primus Remedies Pvt. Ltd. | 13.50 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
tablets | Metformin Hydrochloride IP 1000 mg (as sustained release form) | ||||
29 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg (as Extended-Release form) | 1 Tablet | M/s Zydus Healthcare Ltd. | 11.83 |
30 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg (as Extended Release) | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Alkem Laboratories Ltd. | 11.83 |
31 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Morepen Laboratories Ltd. | 8.03 |
32 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 850 mg | 1 Tablet | M/s Morepen Laboratories Ltd. | 7.13 |
33 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Morepen Laboratories Ltd. | 6.24 |
34 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated bilayered tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg (as Extended-Release form) | 1 Tablet | M/s Zydus Healthcare Ltd. | 19.01 |
35 | Empagliflozin & Metformin Hydrochloride (ER) Tablets | Each film coated tablet contains: Empagliflozin 12.5 mgMetformin Hydrochloride IP 1000 mg (as Extended-Release form) | 1 Tablet | M/s MSN Laboratories Pvt. Ltd./M/s USV Ltd. | 19.01 |
36 | Empagliflozin & Metformin Hydrochloride | Each film coated Bilayered tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd./ M/s Alkem | 19.01 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
(ER) Tablets | 1000 mg (as Extended-Release form) | Laboratories Ltd. | |||
37 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Cadila Pharmaceuticals Ltd. | 19.01 |
38 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Morepen Laboratories Ltd. | 13.38 |
39 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Emcure Pharmaceuticals Ltd. | 19.01 |
40 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Abbott Healthcare Pvt. Ltd. | 17.85 |
41 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Cadila Pharmaceuticals Ltd. | 18.10 |
42 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s USV Ltd. | 18.10 |
43 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Morepen Laboratories Ltd. | 12.49 |
44 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mgMetformin Hydrochloride IP 500 mg | 1 Tablet | M/s Exemed Pharmaceuticals/M/s Emcure Pharmaceuticals Ltd. | 18.10 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
45 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Intas Pharmaceuticals Ltd. | 10.71 |
46 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Exemed Pharmaceuticals/ M/s Abbott Healthcare Pvt. Ltd. | 14.28 |
47 | Empagliflozin & Metformin Hydrochloride Tablets | Each film coated tablet contains: Empagliflozin 12.5 mg Metformin Hydrochloride IP 850 mg | 1 Tablet | M/s Morepen Laboratories Ltd. | 12.94 |
48 | Dapagliflozin & Metoprolol Succinate (as extended release form) tablets | Each film coated bilayer tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg, Metoprolol Succinate eq. to Metoprolol Tartrate (as extended release) 50 mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Ltd. | 17.27 |
49 | Dapagliflozin & Metoprolol Succinate (ER) Tablets | Each film coated bilayer tablet contains: Dapagliflozin propanediol USP eq. to Dapagliflozin 10mg Metoprolol Succinate eq. to Metoprolol Tartrate 50 mg (as extended release) | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Ajanta Pharma Ltd. | 17.14 |
50 | Dapagliflozin & Metoprolol Succinate (ER) Tablets | Each film coated bilayer tablet contains: Dapagliflozin propanediol USP eq. to Dapagliflozin 10mg Metoprolol Succinate eq. to Metoprolol Tartrate 50 mg (as extended release) | 1 Tablet | M/s Exemed Pharmaceuticals /M/s Cipla Ltd. | 17.27 |
51 | Dapagliflozin & Metoprolol Succinate (as extended-release form) tablets | Each film coated bilayer tablet contains: Dapagliflozin Propanediol USP eq. to Dapagliflozin 10 mg, Metoprolol Succinate eq. to Metoprolol Tartrate (as extended release) 25 mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Ltd. | 15.96 |
52 | Metformin oral | Each 5 ml oral solution contains: | 1 ML | M/s Eris Therapeutics | 0.40 |
Sl. No. | Medicines | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
solution | Metformin Hydrochloride IP 500mg | Limited | |||
53 | Cefixime & Erdosteine Capsules | Each hard gelatin capsule contains: Cefixime IP eq. to Cefixime Anhydrous 200 mg Erdosteine 300 mg | 1 Capsule | M/s Macleods Pharmaceuticals Ltd. | 39.08 |
The notice further added:
- The manufacturer of above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
- The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
- The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
- As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
- The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
- (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
- Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2),(3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.
To view the official notice, click the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.